You are here

NEOCLONE BIOTECHNOLOGY INTERNATIONAL

Company Information
Address
1202 Ann St
MADISON, WI 53713-2410
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Reactivation of human cells for novel fully human Ab platform

    Amount: $286,368.00

    DESCRIPTION (provided by applicant): Monoclonal antibodies (mAbs) have been developed into a highly effective class of therapeutic molecules, with global growth of 37% between 2001 and 2002. Since the ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  2. Improving Ovarian Cancer Treatment by Targeting a Novel Epitope of MUC16

    Amount: $190,591.00

    DESCRIPTION (provided by applicant): The CA125 antigen is a well known marker for monitoring the recurrence and progression of epithelial ovarian cancer. It is now clear that this antigen is a repeati ...

    STTRPhase I2009Department of Health and Human Services National Institutes of Health
  3. BIOMARKER SCREENING WITH REVOLUTIONARY NEOABS

    Amount: $206,777.00

    Not Available

    SBIRPhase II2008Department of Health and Human Services National Institutes of Health
  4. BIOMARKER SCREENING WITH REVOLUTIONARY NEOABS

    Amount: $35,615.00

    SBIRPhase II2008Department of Health and Human Services National Institutes of Health
  5. Novel Platform Technology for Developing Therapeutic Human mAbs

    Amount: $140,000.00

    DESCRIPTION (provided by applicant): Despite significant advances in treatment and early detection, cancer remains a significant disease threat to society. Therapeutic monoclonal antibodies are effect ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  6. A novel platform for mining the repertoire of antigen-specific B cells

    Amount: $99,635.00

    DESCRIPTION (provided by applicant): Cancer remains a significant threat to the health and economy of today's society. Advances in cancer research are key to cancer biomarker discovery, develop ...

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  7. BIOMARKER SCREENING WITH REVOLUTIONARY NEOABS

    Amount: $507,208.00

    N/A

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  8. BIOMARKER SCREENING WITH REVOLUTIONARY NEOABS

    Amount: $507,208.00

    N/A

    SBIRPhase I2007Department of Health and Human Services National Institutes of Health
  9. BIOMARK SCRN W REVOLUTIONARY NEOAB ANTIBODIES

    Amount: $100,000.00

    N/A

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government